Edit |   |
---|---|
Antigenic Specificity | MSLN (Anetumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 lambda |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anetumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting MSLN, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Anetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer). |
Immunogen | n/a |
Other Names | Anetumab, MSLN, 1375258-01-7 |
Gene, Accession # | CAS: 1375258-01-7 |
Catalog # | abx831288 |
Price | please inquire |
Order / More Info | MSLN (Anetumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950